Clozapine Normalizes Prefrontal Cortex Dopamine Transmission in Monkeys Subchronically Exposed to Phencyclidine

[1]  S. Kapur,et al.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone. , 2006, Journal of psychiatry & neuroscience : JPN.

[2]  J. Kane,et al.  Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended , 2005, Biological Psychiatry.

[3]  S. Kapur,et al.  Evidence for onset of antipsychotic effects within the first 24 hours of treatment. , 2005, The American journal of psychiatry.

[4]  Patricia S. Goldman-Rakic,et al.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction , 2004, Psychopharmacology.

[5]  Patricia S. Goldman-Rakic,et al.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia , 2004, Psychopharmacology.

[6]  J. Jentsch.  Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs , 2003, Clinical Neuroscience Research.

[7]  Marc Laruelle,et al.  Dopamine Depletion and In Vivo Binding of PET D1 Receptor Radioligands: Implications for Imaging Studies in Schizophrenia , 2003, Neuropsychopharmacology.

[8]  S. Kapur,et al.  Delayed onset hypothesis of antipsychotic action — a hypothesis tested and rejected , 2003, Schizophrenia Research.

[9]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Sampson,et al.  Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization , 2001, The Journal of comparative neurology.

[11]  Michael F. Green,et al.  Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications , 2001, Biological Psychiatry.

[12]  H. Wikström,et al.  Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. , 2001, European journal of pharmacology.

[13]  R. Roth,et al.  Phencyclidine Model of Frontal Cortical Dysfunction in Nonhuman Primates , 2000 .

[14]  R. Roth,et al.  Effects of Antipsychotic Drugs on Dopamine Release and Metabolism in the Central Nervous System , 2000 .

[15]  M. Lidow.  Neurotransmitter Receptors in Actions of Antipsychotic Medications , 2000 .

[16]  M. Pistis,et al.  Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex , 2000, Neuropsychopharmacology.

[17]  R. Roth,et al.  Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment , 1999, Neuroscience.

[18]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[19]  R. Roth,et al.  Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits , 1999, Neuroscience.

[20]  Hank P Jedema,et al.  Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus , 1999, Neuropsychopharmacology.

[21]  M. Diana,et al.  Clozapine potently stimulates mesocortical dopamine neurons. , 1999, European journal of pharmacology.

[22]  R. Roth,et al.  Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys , 1999, Psychopharmacology.

[23]  H. Meltzer,et al.  Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. , 1999, The Journal of pharmacology and experimental therapeutics.

[24]  Allan I. Levey,et al.  Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.

[25]  R. Roth,et al.  Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.

[26]  R. Roth,et al.  Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat , 1997, Neuropsychopharmacology.

[27]  R. Roth,et al.  Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966 , 1997, The Journal of Neuroscience.

[28]  D. Weinberger,et al.  Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.

[29]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[30]  R. Roth,et al.  Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. , 1996, Cell transplantation.

[31]  P S Goldman-Rakic,et al.  Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Hersch,et al.  The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  P. Goldman-Rakic,et al.  Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys , 1994, Psychopharmacology.

[34]  H. Meltzer,et al.  Effects of clozapine on cognitive function in schizophrenia. , 1994, The Journal of clinical psychiatry.

[35]  R. Roth,et al.  Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment , 1994, Neuroscience Letters.

[36]  F. Karoum,et al.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol , 1992, British journal of pharmacology.

[37]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[38]  R. Roth,et al.  Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  B. Bunney,et al.  Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[40]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[41]  Timothy H. Hand,et al.  Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons , 1987, Brain Research.

[42]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.

[43]  Larry R. Squire,et al.  Encyclopedia of neuroscience , 2009 .

[44]  T. Robbins.  Synthesizing schizophrenia: a bottom-up, symptomatic approach. , 2005, Schizophrenia bulletin.

[45]  J. Hagan,et al.  Predicting drug efficacy for cognitive deficits in schizophrenia. , 2005, Schizophrenia bulletin.

[46]  R. Roth,et al.  Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates , 2005, Journal of Neural Transmission.

[47]  A. Grace,et al.  Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. , 2005, Schizophrenia bulletin.

[48]  E. Carboni,et al.  Dopamine reuptake by norepinephrine neurons: exception or rule? , 2004, Critical reviews in neurobiology.

[49]  T. Goldberg,et al.  Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.

[50]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.

[51]  M. Piercey,et al.  Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release , 1998, Journal of Neural Transmission.

[52]  R. Roth,et al.  Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia. , 1998, Advances in pharmacology.